13
Date Page no. PRACTICAL-3 AIM: To prepare and evaluate IR tablet formulation by wet granulation method using ascorbic acid as model drug and to study the effect aqueous and non-aqueous granulating agents. A.Tablets using aqueous granulating agent (hydrophilic binder). B.Tablets using non-aqueous granulating agent (hydrophobic binder). FORMULA: Each tablet contains 250 mg Ascorbic acid I.P. Excipients: Quantity sufficient Batch size: 20 tablets Packaging: Aluminium strip of 10 tablets FORMULATION: A. Tablets using aqueous granulating agent (hydrophilic binder). INGREDIENTS QUANTITY PER TABLET QUANTITY PER 20 TABLETS ROLE OF EACH INGREDIENTS Ascorbic acid 250 mg 5 g Vitamin C supplement Starch paste (10%W/V) q.s. q.s. Binder Microcrystal line 30 mg 0.6 g Diluent and disintegrant

Document3

Embed Size (px)

DESCRIPTION

.

Citation preview

Page 1: Document3

Date Page no.

PRACTICAL-3

AIM: To prepare and evaluate IR tablet formulation by wet granulation method using ascorbic acid as model drug and to study the effect aqueous and non-aqueous granulating agents.

A. Tablets using aqueous granulating agent (hydrophilic binder).B. Tablets using non-aqueous granulating agent (hydrophobic binder).

FORMULA:

Each tablet contains 250 mg Ascorbic acid I.P.

Excipients: Quantity sufficient

Batch size: 20 tablets

Packaging: Aluminium strip of 10 tablets

FORMULATION:

A. Tablets using aqueous granulating agent (hydrophilic binder).

INGREDIENTS QUANTITY PER TABLET

QUANTITY PER 20 TABLETS

ROLE OF EACH INGREDIENTS

Ascorbic acid 250 mg 5 g Vitamin C supplement

Starch paste (10%W/V)

q.s. q.s. Binder

Microcrystalline cellulose (Avicel)

30 mg 0.6 g Diluent and disintegrant

Magnesiun stearate 10 mg 0.2 g Lubricant and glidant

Aerosil (Silicic acid)

5 mg 0.1 g Lubricant and antiadherent

Page 2: Document3

Date Page no.

OBSERVATION TABLE:

A. Tablets using aqueous granulating agent (hydrophilic binder).

1. Weight variation:

2. Hardness:

No. of tablet

Hardness (Kg/cm2)

12345MEAN

No. of tablets

Weight (mg)

1234567891011121314151617181920MEAN

Page 3: Document3

Date Page no.

B.Tablets using non-aqueous granulating agent (hydrophobic binder).

INGREDIENTS QUANTITY PER TABLET

QUANTITY PER 20 TABLETS

ROLE OF EACH INGREDIENTS

Ascorbic acid I.P. 250 mg 5 g Vitamin C supplements

Ethyl cellulose 5% solution in ethanol

q.s. q.s. Binder

Microcrystalline cellulose (Avicel)

30 mg 0.6 g Diluent and disintegrant

Magnesiun stearate 10 mg 0.2 g Lubricant and glidant

Aerosil (Silicic acid)

5 mg 0.1 g Lubricant and antiadherent

PROCEDURE:

1. METHOD OF PREPARATION:A. Tablets using aqueous granulating agent (hydrophilic binder).

PREPARATION OF STARCH PASTE (10%W/V):

10 g of starch powder was weighed accurately and dissolved in 100 ml hot boil water (60◦c) with continuous heating until thick paste was obtained.

PREPARATION OF TABLETS:

Weighed accurately API and microcrystalline cellulose and transferred to mortar to mix properly.

Added sufficient quantity of starch paste (10%W/V) slowly and made up a wet dump mass with suitable consistency.

Passed through it 10 # sieve and dried granules in hot air oven. Dried granules were passed through the arrangements of sieve No, 22 # and

44 # sieves. Granules were collected on 44 # sieve and fines were collected below the 44 # sieve.

Suitable proportion of fines and granules were compressed to tablet under rotary tablet machine with proper tooling.

Page 4: Document3

Date Page no.

3. Friability:

No. of tablet % weight loss

4. Disintegration:

No. of tablet

Disintegration time

12345MEAN

5. Dissolution rate profile:

Tim

e

Abs

rban

ce

Con

c(m

cg/m

l)

Con

c. *

dil.

Fa

ctor

conc

(mcg

/5m

l)

Con

c.(m

cg/9

00m

l)

Cum

.con

c(m

cg/5

ml)

Tot

al

mcg

/900

ml

Tot

al

(mg/

900m

l)

%D

R

Page 5: Document3

Date Page no.

B. Tablets using non-aqueous granulating agent (hydrophobic binder).

Preparation of ethyl cellulose (5%w/v) solution:

2.5 g ethyl cellulose was weighed accurately and dissolved in 50 ml ethanol.

Preparation of tablets:

Weighed accurately API and microcrystalline cellulose and transferred to mortar to mix properly.

Added sufficient quantity of ethyl cellulose (5%W/V) solution slowly and made up a wet dump mass with suitable consistency.

Passed through it 10 # sieve and dried granules in hot air oven. Dried granules were passed through the arrangements of sieve No, 22 # and

44 # sieves. Granules were collected on 44 # sieve and fines were collected below the 44 # sieve.

Suitable proportion of fines and granules were compressed to tablet under rotary tablet machine with proper tooling.

2. METHOD OF CHARACTERIZATION:

1. Weight variation: It was performed by using 20 tablets by alternatively weighing of each tablet on weighing machine.

2. Hardness: It was characterized for each tablet by using the Monsanto tester.

3. Friability: It was performed by subjecting a weighed No. of tablets to Roche Friabilator that revolved at 25 rpm and dropping the tablets.

4. Disintegration: It was performed using USP disintegrating test apparatus.

5. Dissolution rate profile: It was performed by using USP type apparatus.

Tablets using non-aqueous granulating agent (hydrophobic binder).

Page 6: Document3

Date Page no.

1. Weight variation:

2. Hardness:

No. of tablet

Hardness (Kg/cm2)

12345MEANComments:

No. of tablets

Weight (mg)

1234567891011121314151617181920MEAN

Page 7: Document3

Date Page no.

1. If the API is moisture sensitive /hygroscopic, then aqueous granulating agent is not advisable because it may degrade API by hydrolysis/oxidation If the given API is heat sensitive then drying is necessary which can be achieved non-aqueous granulation easily.

2. In the formulation where the wet granulation method is only advisable method when choice of granulating agent is critical depending on the sensitivity of API.

3. In present study, the effect of aqueous and non- aqueous binder solution on stability of moisture sensitive API is investigated by key parameters like content and dissolution profile.

NOTE: The formulation characterizes after 6-8 hours of the formulation.

The observations show that the hydrophobic granulating agent for the moisture sensitive API is important as binding agent which increase the stability of formulation.

Page 8: Document3

Date Page no.

3. Friability:

No. of tablet % weight loss

4. Disintegration:

No. of tablet

Disintegration time

12345MEAN

5. Dissolution profile

Tim

e

Abs

rban

ce

Con

c(m

cg/m

l)

Con

c. *

dil.

Fa

ctor

conc

(mcg

/5m

l)

Con

c.(m

cg/9

00m

l)

Cum

.con

c(m

cg/5

ml)

Tot

al

mcg

/900

ml

Tot

al

(mg/

900m

l)

%D

R

Page 9: Document3

Date Page no.

REFERENCE :

Pharmaceutical dosage forms: Tablet volume 1, edited by Herbert A Liebermann and Leon Lachmann.